1a/🌞Hello everyone, welcome to the #WorldDiabetesDay #skeetorial on behalf of @theisn.org @who.int ⁉️Let us begin with a quiz 🎊Do you know the theme of World Diabetes Day 2025? a/ Breaking barriers, bridging gaps b/ Family and diabetes c/ Access to diabetes care d/ Diabetes across life stages

Longitudinal Trajectories of Chronic #Kidney Disease-Associated #Pruritus #VisualAbstract by Kajaree https://www.kireports.org/article/S2468-0249(25)00667-9/fulltext

😣CKD associated #pruritus is a fluctuating symptom with prevalence of 53% 🚨Associated with higher fatigue and lower sleep quality @theisn.org @kireports.bsky.social @myadla.bsky.social @isn-india.bsky.social

#LiverCyst #Infection Outcomes in Patients With Autosomal Dominant Polycystic Kidney Disease #ADPKD #VisualAbstract by Kajaree https://www.kireports.org/article/S2468-0249(25)00671-0/fulltext

The 2025 @kdigo.org IgAN guideline quietly redraws the map: new drugs, new thresholds, and a sense that the era of “supportive care only” is finally over #Nephsky #Medsky ✍️Summary by @thekidneywhisperer.bsky.social and @glomerican.bsky.social www.nephjc.com/news/igan-kd...

Register NOW for #ISNCON25 ✅ Conference Registration isncon2025lucknow.com/registration ✅ Workshop Registration www.isncon2025.com/workshop-registration Pre-Conf Workshop -Critical Care Nephrology & POCUS -18th Dec 2025 📌 Free Registration for the Workshop! (But you must register for the Conference)

💊Finerenone in Heart Failure and Chronic Kidney Disease with Type 2 Diabetes: The Fine-Heart Pooled Analysis ✅Significantly lower deaths of any cause, CV events and kidney outcomes but failed to demonstrated significant reductions in CV death #NephJC #finerenone @theisn.org @nephjc.bsky.social

⏬Low Cystatin C/creatinine eGFR ratio in kidney transplant recipients is associated with MACE 🌟DM, male gender, myosteatosis, low muscle mass are key factors of such low ratio 🎊Thank you @kidneyint.bsky.social for the opportunity @theisn.org @isn-india.bsky.social #visualabstract

✅FACT Trial @theisn.org

📣 Only two weeks left to submit your WCN’26 abstract! Don’t miss the chance to: 🌍 gain recognition at the 2026 global kidney care event 🏆 win one of 3 prestigious awards 📰 get your work published in KIReports® congress supplement Submit by October 22➡️http://lite.spr.ly/6...

✅Mayo MGRS Prediction Tool has good performance in finding the risk of MGRS in kidney biopsy in patients with MG 🔆Happy to contribute in this #videoabstract 🎉Thank you @theisn.org and @dilushiwijay.bsky.social for the opportunity @myadla.bsky.social @arvindcanchi.bsky.social

The 54th Annual Conference of the Indian Society of Nephrology will be held in Lucknow in December 2025. Abstract submission closes on 31st July 2025. Submit your abstracts NOW 👉 isn-india.org/isn_registra... @kajareeg.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social

The 54th Annual Conference of the Indian Society of Nephrology #ISNCON25 will be held in Lucknow in December. Beat the deadline ‼️ Submit your abstract NOW at www.isncon2025.com @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social @kajareeg.bsky.social @arvindcanchi.bsky.social

🌟 Welcome to WIN ICON 2025 in vibrant Chennai! 🌟 We’re delighted to host brilliant minds, esteemed faculty & passionate delegates for days of learning, collaboration & innovation in nephrology. Let the academic exchange begin! 🩺📚✨ #WINICON2025 #Chennai

🎉Wonderful tweetorial on behalf of @theisn.org on the occasion of #WorldSnakeDay

𝗧𝗢𝗗𝗔𝗬: ISN GREEN-K Webinar: "Advances in Green Technologies." 🗣️ Karin Gerritsen, Joseph Chin-Chi Kuo 👥 Ehab Hafiz, Winston Fung 🗓️ July 8 🕑 2:00 pm CEST 🔗 Free registration: http://lite.spr.ly/6... #GreenNephrology

A New Episode of the Kidney Konversations podcast - Episode 11 - Genetic testing in kidney disease is available on Spotify at this link 👉 open.spotify.com/episode/3xO6... #genetics #nephsky @kajareeg.bsky.social @isn-india.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social

📢Lets check out the #visualabstract from @kireports.bsky.social 🧬The genetic variability of the FAM47E-SHROOM3 haplotypes indicates distinct biochemical patterns www.kireports.org/article/S246...

📢Both prognostic models IIgAN-PT and Bednarova-PT had good discriminatory ability to predict renal allograft outcomes after IgAN recurrence post KT 🍃Thank you @kireports.bsky.social for the opportunity and @nephjc.bsky.social and #NSMCInternship for the training!

Combination #Cyclophosphamide and #Rituximab to Minimize #Glucocorticoid Use in Antineutrophil Cytoplasm Antibody–Associated Vasculitis #ANCA #VisualAbstract by @KajareeG www.kireports.org/ar...

📢Lets check out the #skeetorial on occasion of #WorldKidneyCancerDay 💝Show your kidneys some love! @theisn.org @isn-india.bsky.social @ikccorg.bsky.social #Nephsky #Medsky #WKCD2025

Folks ! we are back for our monthly session of #ECNeph Join us tomorrow at 12 PM EST with @dramiliflores.bsky.social @renfamilia.bsky.social for an exciting case discussion on BS Happening TODAY 9:30 PM IST on X @theisn.org @kajareeg.bsky.social @dilushiwijay.bsky.social

Starts in 20 min ! Eager to engage for an exciting discussion ? Join us with #ECNeph Share your thoughts @theisn.org @kajareeg.bsky.social @divyaveerssneph.bsky.social @dilushiwijay.bsky.social

7/n IgG4-RD Clinical Phenotypes: One Disease, Many Faces 🎭🧬 📖https://www.bmj.com/content/369/bmj.m1067 #ECNeph @myadla.bsky.social @dramiliflores.bsky.social @dilushiwijay.bsky.social @kajareeg.bsky.social @theisn.org

Friends ! Check this survey on Pregnancy AKI Available in 20 languages Do share in your groups qualtrics.kcl.ac.uk/jfe/form/SV_... @dramiliflores.bsky.social @hswapnil.medsky.social @divyaveerssneph.bsky.social @kajareeg.bsky.social @dakidneydoc.bsky.social

A glimpse at the causes of an Acquired Bartter Defect too! #ECNeph @myadla.bsky.social @dramiliflores.bsky.social @dilushiwijay.bsky.social @kajareeg.bsky.social @theisn.org @nephroseeker.medsky.social

Hello, Kajaree here from India.. excited for an interesting discussion..no COI #nephsky #ecneph

Upcoming #ECNeph: ⚖️ Guilty Gut or Conspiring Kidneys? 🗓️ April 25 – 12 PM EST 🧠 Join @dakidneydoc.bsky.social @dramiliflores.bsky.social @dilushiwijay.bsky.social @kajareeg.bsky.social @theisn.org #NephSky #MedSky

🔈Happening today ! 12 PM EST .. Join us ! Lurk/Learn ! Use #ECNeph in all your posts .. @dakidneydoc.bsky.social @dramiliflores.bsky.social @dilushiwijay.bsky.social @kajareeg.bsky.social @theisn.org

🚨ANCA vasculitis demands prompt diagnosis and management 🎉Thank you @nephsky.bsky.social @nephjc.bsky.social NSMC internship and the mentors @kidneyboy.bsky.social @hswapnil.medsky.social @brianrifkin.bsky.social @nephroseeker.medsky.social for providing me this opportunity!

SAVE YOUR DATE for upcoming #ECNeph session 🗓️ 24th April 9:30 PM IST on X 🗓️25th April 12 PM EST on BS Interesting case of dyselectrolytemia by @dakidneydoc.bsky.social Moderated by @myadla on X and @dramiliflores.bsky.social on BS @dilushiwijay.bsky.social @kajareeg.bsky.social @theisn.org

🚨 Don’t miss out! 🎤 Present your work at @isn-india.bsky.social ’s flagship #ISNCON2025 in Lucknow! ✨ 📢 Abstracts accepted now→ Published in 📖 IJN Publications. 🔗 Submit here 👉 isn-india.org/isn_registra... @arvindcanchi.bsky.social @kajareeg.bsky.social @jasminenephro.bsky.social

✨ #ISNCON2025 Lucknow Awaits! 🎖️India's Premier #Nephrology Event by @isn-india.bsky.social 🤞🏽Learn ∙ 🤝 Connect ∙ 🌟 Grow 📢 Early bird discounts (Hurry!) 🎓 50% off for students 🔗 Register now: isn-india.org/isn_registrati… @arvindcanchi.bsky.social @kajareeg.bsky.social @jasminenephro.bsky.social

Hey Folks ! An exciting discussion #ECNeph Dont forget to join us! on X (27th March) on BS on 28th March Lets learn together ! @divyaveerssneph.bsky.social @dilushiwijay.bsky.social @acidosistubular.bsky.social @saiachi1.bsky.social @kajareeg.bsky.social @drsumanbehera.bsky.social

Join us this Wednesday for the @isn-india.bsky.social Journal club where we explore the latest evidence on Obinutuzumab in Lupus Nephritis 🗓️ 19th March ⏰ 8-9 pm IST ▶️ Register now us02web.zoom.us/j/8949743288... @kajareeg.bsky.social @sayalibthakare.bsky.social @thisis-drgsp2.bsky.social

18/n🧬 Fabry Treatment Options 🚀 🔹 ERT 💉 – Agalsidase alfa/beta 🔹 Chaperone Therapy 🏥 – Migalastat (for amenable GLA mutations) 🔹 SRT 🛑 – In trials! 🔹 Gene Therapy 🧬 – Future potential! #ECNeph @myadla.bsky.social @theisn.org @arunkumarnephro.bsky.social

20/n 🩺 Fabry ERT in India 🇮🇳 – When to Start? 👨 Males 💉 ✅ Symptomatic → Start ERT ASAP 🔍 Asymptomatic → Monitor, consider early ERT 👩 Females 🚺 ✅ Organ involvement → ERT 🔍 Mild/asymptomatic → Follow-up, delayed ERT if needed #ECNeph @myadla.bsky.social @theisn.org @arunkumarnephro.bsky.social

Lets check mechanisms of action of HCQ ! @arunkumarnephro.bsky.social @kajareeg.bsky.social #ECNeph

Hello all, Dr Kajaree here, joining from India🇮🇳 Excited for this case. No COI #ECNeph

🎉 Let's join today at 9.30 pm IST

Happening in few hours. 📍Exciting discussions on genetics in glomerular diseases 📍Join us at 8 PM IST on Feb 25, 2025, for an engaging session featuring expert talks & unique case presentations.

𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the Industry Webinar: "A New Dawn for IgA Nephropathy – Redefining What is Possible With Sparsentan." 🗣️ Nasim Wiegley and Sydney Tang 🗓️ March 11 🕒 3 pm CET 🔗 Free registration: www.theisn.org/blog/...

𝗦𝗔𝗩𝗘 𝗧𝗛𝗘 𝗗𝗔𝗧𝗘 for the next #ECNeph case: "A Tale of Two Troubles: Diagnostic Dilemma." 🗣️ @arunkumarnephro.bsky.social 👤 @myadla.bsky.social 🗓️ March 7 🕤 9:30 pm IST Do join us for an interesting case scenario!

SAVE THE DATE ! #ECNEPH on 6th March on X /7th March on Bluesky 9:30 PM IST Do join us for an interesting case scenario 🗣️ @Arunkr_Dr 👤 @myadla.bsky.social @theisn.org @isn-india.bsky.social

Hello, Kajaree here from India, no COI #nephJC

🎉#WorldKidneyDay advocacy activity starts with @WomenNeph_india webinar! 📢Let's join in today 21st Feb at 7 pm IST ▶️Link in the image @myadla.bsky.social @elbaonelida.bsky.social

Excited and thrilled! Only 3 days left for #ISNWCN. Explore the scientific program and find all details at events.theisn.org/wcn25/progra... Download the congress app for easy access @theisn.org @sayalibthakare.bsky.social @divyaveerssneph.bsky.social @kajareeg.bsky.social

🎉 Thrilled to share our commentary in Kidney International Reports ✅Is it time to expand the use of SGLT2 inhibitors in KTRs? ▶️Read on www.kireports.org/article/S246... @theisn.org @kireports.bsky.social @myadla.bsky.social @hswapnil.medsky.social @brianrifkin.bsky.social